DVA · Full Picture

DAVITA INC. — the full picture

Earnings window · 2026-07-14 to 2026-08-09 · anchored on the 10-Q report

One earnings window, everything merged: the filing, the call, press releases and news digests, folded into ranked threads.

What to look at first

  1. Guidance / Outlook · Guidance & outlookPriority 73
    2 sources (news, press_release); 4 forward row(s); quote_verified
    Adjusted operating income guidance for full year 2026 is $2,150 million to $2,250 million.
  2. Operating Cash Flow Trends · Cash flow generationPriority 70
    3 sources (news, press_release, sec_filing); quote_verified
    DaVita projected 2026 free cash flow of $1 billion to $1.25 billion.
  3. Interest Rate Environment · Interest ratesPriority 68
    1 forward row(s); quote_verified
    On July 7, 2026 DaVita entered into forward interest rate cap agreements with aggregate notional amount of $750,000 that become effective December 29, 2028 and expire December 31, 2029
  4. Reimbursement and Payer Mix · Compliance & policy costsPriority 66
    2 sources (news, sec_filing); quote_verified
    U.S. dialysis average patient service revenue per treatment for six months ended June 30, 2026 increased $14.33 (3.6%) to $416.71 primarily driven by Medicare base rate and other annual rate increases
  5. Integrated Kidney Care Growth · UnclassifiedPriority 65
    2 sources (press_release, sec_filing); 1 forward row(s); quote_verified
    As of June 30, 2026, approximately 64,900 patients were in risk-based integrated care arrangements representing approximately $5.8 billion in annualized medical spend.
  6. Operating Expense Trends · Operating expenses (SG&A)Priority 63
    -4.7% operating_income; 2 sources (press_release, sec_filing); 1 forward row(s); structured_verified
    As of June 30, 2026, total estimated but unrecognized stock-based compensation expense: $195,359 to be recognized over weighted average remaining period of 1.4 years
  7. Debt and Liquidity Position · Debt, leverage & refinancingPriority 62
    quote_verified
    Entered an incremental Term Loan B-2 tranche in the aggregate principal amount of $500 million in June 2026.
  8. Operating Income and Margins · Operating income & profitabilityPriority 62
    2 sources (news, sec_filing); quote_verified
    DaVita raised its 2026 guidance for adjusted operating income to between $2.15 billion and $2.25 billion.
  9. Share Repurchase Activity · Buybacks & dividendsPriority 61
    -3.0% cash (realized); structured_verified
    As of July 31, 2026 the Company has $1,372,960 available under current authorizations for additional share repurchases (excluding excise taxes)
  10. Net Income and EPS Performance · Operating income & profitabilityPriority 58
    quote_verified
    Income before income taxes for the six months ended June 30, 2026: $776,244
  11. Outstanding Indebtedness · Debt, leverage & refinancingPriority 57
    quote_verified
    Total debt at June 30, 2026 was $10,848 million (total debt, excluding debt discount and other deferred financing costs).
  12. Geographic Market Commentary · Geographic mixPriority 56
    quote_verified
    As of June 30, 2026, the international dialysis business owned or operated 595 outpatient dialysis centers located in 14 countries outside of the United States

Threads by pillar

Revenue & Demand Priority 71 · 5 threads

Costs & Margins Priority 77 · 3 threads

Capital & Balance Sheet Priority 90 · 9 threads

Strategy & Portfolio Priority 59 · 3 threads

Legal, Regulatory & Policy Priority 75 · 4 threads

Guidance & Outlook Priority 73 · 1 thread

Macro & Market Conditions Priority 72 · 2 threads

Unclassified Priority 81 · 5 threads

Expected impact by metric

metricforward netforward grossrealized
operating_income-4.7%+4.7%—
liability-1.3%+1.3%-2.8%
revenue+0.6%+0.6%—
cash——-4.3%
assets——+1.3%
net_income——+1.9%